☆ 4.8 Article

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Oncology

Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis

Marta Santisteban et al.

Summary: The study demonstrated that adding DCV to NAC in breast cancer patients is safe and can increase pathological complete response rate, especially benefiting PD-L1-negative tumors. DCV modify the tumor environment and induce cellular and humoral responses in peripheral blood without impacting outcomes.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)

Add to Collection

Review Oncology

Therapeutic cancer vaccines

Mansi Saxena et al.

Summary: Therapeutic cancer vaccines aim to induce tumor regression, eradicate minimal residual disease, establish lasting anti-tumor memory, and avoid non-specific or adverse reactions. However, challenges arise due to tumor-induced immunosuppression and immunoresistance, hindering the achievement of these goals.

NATURE REVIEWS CANCER (2021)

Add to Collection

Article Immunology

Mutation position is an important determinant for predicting cancer neoantigens

Aude-Helene Capietto et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Add to Collection

Article Oncology

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer

Yi Xiao et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Multidisciplinary Sciences

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Derin B. Keskin et al.

NATURE (2019)

Add to Collection

Article Oncology

Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

Valsamo Anagnostou et al.

CANCER DISCOVERY (2017)

Add to Collection

Article Multidisciplinary Sciences

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

Ugur Sahin et al.

NATURE (2017)

Add to Collection

Letter Medicine, General & Internal

Tumor Mutational Burden and Response Rate to PD-1 Inhibition

Mark Yarchoan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Article Oncology

Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity

Xiuli Zhang et al.

CANCER IMMUNOLOGY RESEARCH (2017)

Add to Collection

Review Pathology

Role of inflammatory infiltrates in triple negative breast cancer

Hirofumi Matsumoto et al.

JOURNAL OF CLINICAL PATHOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

Beatriz M. Carreno et al.

SCIENCE (2015)

Add to Collection

Article Immunology

Induction of Multiepitopic and Long-Lasting Immune Responses Against Tumour Antigens by Immunization with Peptides, DNA and Recombinant Adenoviruses Expressing Minigenes

M. Durantez et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)

Add to Collection

Article Immunology

Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals

Sebastian Kreiter et al.

JOURNAL OF IMMUNOLOGY (2008)

Add to Collection

Article Oncology

Combined immunization with adjuvant molecules poly(I : C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects

Diana Llopiz et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.